Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abnova, Adjuvance, Aetion, Be The Match, Cabaletta, Centivax, Cytodyn, Dyne, Genocea, Match, Haliodx, Imcheck, Innovation Pharmaceuticals, Ipsen, Innovent, Merck & Co., Nantkwest, Onxeo, Oragenics, Pharmajet, Primary Peptides, Prellis, Promis, Qingdao Primedicine, Revance, Rising Pharma, Ritter, Sernova, Shionogi, Sophiris, Therapix, Timber, Xenetic.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Agios, Amplyx, Arbutus, Biogen, Covis, Hepion, Lidds, Mezzion, MGB Biopharma.

Biopharmas raising money in public or private financings, including: Amplyx, Applied Molecular Transport, Axcella, Akers, Bellerophon, Bluebird, Cardiff, Clovis, Cowen, Gamida, Gossamer, Inventiva, Kiniksa, Krystal, Nivagen, Plx Pharma, Tricida, Xbrane.

New hires and promotions in the biopharma industry, including: Addex, Akcea, Ardelyx, Asklepios, Cellectis, Evox, Matrisys, Merck, Oligomerix, Selexis, Science 37, Tonix.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 1drop, Agilent, Edwards, Everlywell, Fulgent Genetics, Zebra Medical Vision.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Apollo Hospitals Group, Beckman Coulter, Behold.ai, Dascena, Illumina, Natera, Philips Healthcare US, Pulmonx, Qiagen, Renalytix AI, SyntheticMR, Thermo Fisher Scientific.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Blue Earth Diagnostics, Sight Sciences, Teleflex.

Med-tech firms raising money in public or private financings, including: Gatt Technologies, Inari Medical.

New hires and promotions in the med-tech industry, including: Gatt Technologies, Locate Bio, Medtronic, Theranica.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adamis, Akebia, Astrazeneca, Biosig, BMS, Carsgen, Cyclo, Cytodyn, Daiichi, Genentech, Lidds, Nantkwest, Sellas, Teva, Vistagen.